Jacques Vignon

1.5k total citations
54 papers, 1.4k citations indexed

About

Jacques Vignon is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Jacques Vignon has authored 54 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 40 papers in Cellular and Molecular Neuroscience and 5 papers in Oncology. Recurrent topics in Jacques Vignon's work include Neuroscience and Neuropharmacology Research (34 papers), Receptor Mechanisms and Signaling (28 papers) and Neurotransmitter Receptor Influence on Behavior (14 papers). Jacques Vignon is often cited by papers focused on Neuroscience and Neuropharmacology Research (34 papers), Receptor Mechanisms and Signaling (28 papers) and Neurotransmitter Receptor Influence on Behavior (14 papers). Jacques Vignon collaborates with scholars based in France, Germany and United States. Jacques Vignon's co-authors include Jean‐Marc Kamenka, Robert Chicheportiche, Michel Lazdunski, Hélène Hirbec, P. Geneste, Tangui Maurice, Isabelle Chaudieu, J.M. Kamenka, Catherine Cerruti and Valérie Pinet and has published in prestigious journals such as PLoS ONE, Biochemistry and Diabetes.

In The Last Decade

Jacques Vignon

54 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques Vignon France 20 912 849 106 104 86 54 1.4k
Sebastian Lazareno United Kingdom 27 1.8k 2.0× 2.5k 2.9× 133 1.3× 72 0.7× 123 1.4× 55 2.9k
Petra Scholze Austria 25 1.3k 1.4× 1.2k 1.4× 67 0.6× 24 0.2× 117 1.4× 69 2.0k
Anne T. Bruinvels Switzerland 15 1.0k 1.1× 1.1k 1.3× 104 1.0× 15 0.1× 78 0.9× 20 1.5k
Francesca Vaglini Italy 17 529 0.6× 477 0.6× 41 0.4× 39 0.4× 58 0.7× 72 1.2k
Nathaniel Calloway United States 9 434 0.5× 582 0.7× 54 0.5× 42 0.4× 29 0.3× 9 1.1k
Alexander Surin Russia 16 496 0.5× 811 1.0× 65 0.6× 24 0.2× 49 0.6× 49 1.2k
Bruce M. Baron United States 20 413 0.5× 439 0.5× 157 1.5× 53 0.5× 47 0.5× 38 967
Marco Favaron Italy 18 1.1k 1.2× 1.1k 1.3× 32 0.3× 17 0.2× 53 0.6× 24 1.8k
Cristina Cosi France 27 1.1k 1.2× 939 1.1× 160 1.5× 22 0.2× 145 1.7× 51 2.1k
Daria Milani Italy 15 499 0.5× 693 0.8× 29 0.3× 28 0.3× 29 0.3× 18 1.1k

Countries citing papers authored by Jacques Vignon

Since Specialization
Citations

This map shows the geographic impact of Jacques Vignon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Vignon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Vignon more than expected).

Fields of papers citing papers by Jacques Vignon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Vignon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Vignon. The network helps show where Jacques Vignon may publish in the future.

Co-authorship network of co-authors of Jacques Vignon

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Vignon. A scholar is included among the top collaborators of Jacques Vignon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Vignon. Jacques Vignon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hassani, Zahra, Ali Saleh, Salim Khiati, et al.. (2017). Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation. Molecular Cancer Research. 15(10). 1376–1387. 33 indexed citations
2.
Ulmann, Lauriane, Marisa Teigell, Jacques Vignon, et al.. (2013). Development of NMDAR Antagonists with Reduced Neurotoxic Side Effects: a Study on GK11. PLoS ONE. 8(11). e81004–e81004. 11 indexed citations
3.
Lajoix, Anne‐Dominique, et al.. (2007). Expression of purinergic P2Y receptor subtypes by INS-1 insulinoma β-cells: A molecular and binding characterization. European Journal of Pharmacology. 568(1-3). 54–60. 22 indexed citations
4.
Farret, Anne, Nathalie Linck, M. Manteghetti, et al.. (2006). P2Y Receptor Mediated Modulation of Insulin Release by a Novel Generation of 2-Substituted-5′-O-(1-Boranotriphosphate)-Adenosine Analogues. Pharmaceutical Research. 23(11). 2665–71. 19 indexed citations
5.
Hirbec, Hélène, et al.. (2002). Re‐evaluation of phencyclidine low‐affinity or “non‐NMDA” binding sites. Journal of Neuroscience Research. 68(3). 305–314. 5 indexed citations
6.
Hirbec, Hélène, J.M. Kamenka, Alain Privat, & Jacques Vignon. (2001). Characterization of 'non-N-methyl-d-Aspartate' binding sites for gacyclidine enantiomers in the rat cerebellar and telencephalic structures. Journal of Neurochemistry. 77(1). 190–201. 10 indexed citations
7.
Hirbec, Hélène, J.M. Kamenka, Alain Privat, & Jacques Vignon. (2001). Interaction of gacyclidine enantiomers with ‘non-NMDA’ binding sites in the rat central nervous system. Brain Research. 894(2). 189–192. 11 indexed citations
8.
Hirbec, Hélène, Manuel Gaviria, & Jacques Vignon. (2001). Gacyclidine: A New Neuroprotective Agent Acting at the N‐Methyl‐D‐Aspartate Receptor. CNS Drug Reviews. 7(2). 172–198. 47 indexed citations
9.
Hirbec, Hélène, Alain Privat, & Jacques Vignon. (2000). Binding properties of [3H]gacyclidine in the rat central nervous system. European Journal of Pharmacology. 388(3). 235–239. 8 indexed citations
10.
Prinssen, E., Wouter Koek, Jacques Vignon, Jean‐Marc Kamenka, & Mark S. Kleven. (1999). Does crossing over repeated treatment with the dopamine reuptake inhibitors cocaine and BTCP modify their effects on cocaine-induced locomotion?. Psychopharmacology. 143(1). 8–14. 3 indexed citations
11.
Kleven, Mark S., Jean‐Marc Kamenka, Jacques Vignon, & Wouter Koek. (1999). Pharmacological characterization of the discriminative stimulus properties of the phencyclidine analog, N -[1-(2-benzo(b)thiophenyl)-cyclohexyl]piperidine. Psychopharmacology. 145(4). 370–377. 14 indexed citations
12.
Martin‐Fardon, Rémi, et al.. (1997). Long-term monitoring of extracellular dopamine concentration in the rat striatum by a repeated microdialysis procedure. Journal of Neuroscience Methods. 72(2). 123–135. 28 indexed citations
13.
14.
Lockhart, Brian, et al.. (1995). A N-methyl-d-aspartate receptor-mediated neurotoxic effect of aspartate-based hydroxamate compounds in rat primary neuronal cultures. Brain Research. 670(2). 313–316. 6 indexed citations
15.
Chergui, Karima, H. Akaoka, P. J. Charléty, et al.. (1992). Inhibition of locus coeruleus neurons by the phencyclidine analog, N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine: evidence for potent indirect adrenoceptor agonist properties. European Journal of Pharmacology. 219(1). 169–172. 2 indexed citations
16.
Maurice, Tangui, G. Barbanel, J.M. Kamenka, & Jacques Vignon. (1991). Modulation by dopamine of [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3h]btcp, a phencyclidine derivative) binding to the dopamine uptake complex. Neuropharmacology. 30(6). 591–598. 37 indexed citations
17.
18.
Vignon, Jacques, Valérie Pinet, Catherine Cerruti, Jean‐Marc Kamenka, & Robert Chicheportiche. (1988). [3H]N-[1-(2-Benzo(b)thiophenyl) cycohexyl]piperidine ([3H]BTCP): a new phencyclidine analog selective for the dopamine uptake complex. European Journal of Pharmacology. 148(3). 427–436. 133 indexed citations
19.
Kamenka, J.M., et al.. (1985). Recherche de différences conformationnelles et biochimiques entre phencyclidine et kétamine. 20(5). 419–424. 5 indexed citations
20.
Vincent, Jean‐Pierre, et al.. (1980). Binding of phencyclidine to rat membranes: Technical aspect. European Journal of Pharmacology. 68(1). 73–77. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sebastian Lazareno Breakdown of academic impact, for papers by Petra Scholze Breakdown of academic impact, for papers by Anne T. Bruinvels Breakdown of academic impact, for papers by Francesca Vaglini Breakdown of academic impact, for papers by Nathaniel Calloway Breakdown of academic impact, for papers by Alexander Surin Breakdown of academic impact, for papers by Bruce M. Baron Breakdown of academic impact, for papers by Marco Favaron Breakdown of academic impact, for papers by Cristina Cosi Breakdown of academic impact, for papers by Daria Milani
Rankless by CCL
2026